Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.51
+0.41 (2.04%)
Sep 2, 2026, 10:06 AM EDT - Market open

Syndax Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
252.25172.3523.68--139.71
Revenue Growth
223.68%627.84%---9109.56%
Gross Profit
-20.2-93.4-218.79-163.03-118.5139.71
Operating Income
-194.17-273.08-339.67-229.95-151.7626.22
Net Income
-220.77-285.42-318.76-209.36-149.3424.93
Earnings Per Share
-2.51-3.29-3.72-2.98-2.460.46
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
554.27413.69582.91577.58484.4446.83
Total Debt
589.38345.43345.741.641.1620.97
Net Cash (Debt)
-35.1268.25237.17575.95483.24425.86
Net Cash Growth
--71.22%-58.82%19.19%13.47%53.62%
Net Cash Per Share
-0.400.792.778.187.957.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-220.64-322.98-274.9-160.6-133.6829.13
Capital Expenditures
-0.23-0.19----0.13
Free Cash Flow
-220.87-323.17-274.9-160.6-133.6829
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-8.01%-54.19%---100.00%
Operating Margin
-76.98%-158.45%-1434.43%--18.77%
Pretax Margin
-87.52%-165.60%-1346.11%--17.84%
Profit Margin
-87.52%-165.60%-1346.11%--17.84%
FCF Margin
-87.56%-187.50%-1160.91%--20.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----47.49
P/FCF Ratio
-----40.81
PS Ratio
7.1210.6047.65--8.47